🇺🇸 FDA

Drug profile · INN

crizotinib

XALKORI

FDA: approved EMA: approved TGA: approved PMDA: approved NMPA: clinical trials L01ED01
US status
approved
Patents linked
0
News articles
0

Quick answer

crizotinib (XALKORI) is an FDA-listed pharmaceutical active ingredient. Associated with Pfizer Australia Pty Ltd. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN crizotinib
Brand XALKORI
Route ORAL
Formulation CAPSULE
ATC code L01ED01
Originator Pfizer Australia Pty Ltd

Frequently asked questions

What is crizotinib?

crizotinib (XALKORI) is an FDA-listed pharmaceutical active ingredient. Associated with Pfizer Australia Pty Ltd. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for crizotinib?

XALKORI is a marketed brand name for crizotinib. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of crizotinib?

crizotinib has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.